Acute effects of low-dose interferon-α on serum cortisol and plasma interleukin-6

被引:25
作者
Cassidy, EM
Manning, D
Byrne, S
Bolger, E
Murray, F
Sharifi, N
Wallace, E
Keogan, M
O'Keane, V
机构
[1] Beaumont Hosp, Royal Coll Surg Ireland, Dept Psychiat, Dublin, Ireland
[2] Beaumont Hosp, Royal Coll Surg Ireland, Dept Gastroenterol, Dublin, Ireland
[3] Beaumont Hosp, Royal Coll Surg Ireland, Dept Endocrinol, Dublin, Ireland
[4] Beaumont Hosp, Royal Coll Surg Ireland, Dept Immunol, Dublin, Ireland
关键词
cytokine; depression; HPA axis; interferon alpha; interleukin-6;
D O I
10.1177/026988110201600307
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Major depression is associated with both hypothalamic-pituitary-adrenal (HPA) axis overactivity and immune system activation. Depression is a common occurrence following interferon (IFN)-alpha treatment. While IFN-alpha is known to stimulate the HPA axis, little is known about the effects of exogenous IFN-alpha in humans on the proinflammatory cytokine interleukin (IL)-6, a marker of immune system activation. This study examined the acute effects of IFN-alpha on cortisol and IL-6 release, and the time course of any changes in these variables. Serum cortisol and plasma IL-6 were assessed in healthy volunteers over an 8-h period following 3 million units subcutaneous IFN-alpha or placebo using a double-blind, placebo-controlled crossover design. IFN-alpha resulted in a significant increase in both cortisol and IL-6. Regular sampling over 8 h did not delineate any sequential effect of the rise in these variables over time. We conclude that IFN-alpha acutely stimulates both the HPA axis and proinflammatory cytokine release. The hypothesis that the effect of IFN-alpha on the HPA axis is indirect and mediated by IL-6 was not supported by this study. Our findings are nonetheless of relevance to the aetiology of depression following IFN-alpha.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 28 条
[1]  
[Anonymous], 1997, NIH Consens Statement, V15, P1
[2]   DEXAMETHASONE INHIBITION OF INTERFERON-ALPHA-2-INDUCED STIMULATION OF CORTISOL AND GROWTH-HORMONE SECRETION IN CHRONIC MYELOPROLIFERATIVE SYNDROME [J].
BARBARINO, A ;
COLASANTI, S ;
CORSELLO, SM ;
SATTA, MA ;
DELLACASA, S ;
ROTA, CA ;
TARTAGLIONE, R ;
BARINI, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1329-1332
[3]   HUMAN-LEUKOCYTE INTERFERON - STRUCTURAL AND BIOLOGICAL RELATEDNESS TO ADRENOCORTICOTROPIC HORMONE AND ENDORPHINS [J].
BLALOCK, JE ;
SMITH, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (10) :5972-5974
[4]   Combination therapy with interferon-α and ribavirin for hepatitis C -: Practical treatment issues [J].
Collier, J ;
Chapman, R .
BIODRUGS, 2001, 15 (04) :225-238
[5]   Endocrine and metabolic effects of interferon-alpha in humans [J].
Corssmit, EPM ;
Heijligenberg, R ;
Endert, E ;
Ackermans, MT ;
Sauerwein, HP ;
Romijn, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3265-3269
[6]   ACUTE EFFECTS OF INTERFERON-ALPHA ADMINISTRATION ON THYROID-HORMONE METABOLISM IN HEALTHY-MEN [J].
CORSSMIT, EPM ;
HEYLIGENBERG, R ;
ENDERT, E ;
SAUERWEIN, HP ;
ROMIJN, JA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (11) :3140-3144
[7]   Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review [J].
Dieperink, E ;
Willenbring, M ;
Ho, SB .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (06) :867-876
[8]   GLUCOCORTICOIDS AND THE GENESIS OF DEPRESSIVE-ILLNESS - A PSYCHOBIOLOGICAL MODEL [J].
DINAN, TG .
BRITISH JOURNAL OF PSYCHIATRY, 1994, 164 :365-371
[9]   PSYCHOPATHOLOGY IN PATIENTS WITH ENDOGENOUS CUSHINGS-SYNDROME - ATYPICAL OR MELANCHOLIC FEATURES [J].
DORN, LD ;
BURGESS, ES ;
DUBBERT, B ;
SIMPSON, SE ;
FRIEDMAN, T ;
KLING, M ;
GOLD, PW ;
CHROUSOS, GP .
CLINICAL ENDOCRINOLOGY, 1995, 43 (04) :433-442
[10]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454